Case Report: Desmoid tumor response to magnetic resonance-guided high intensity focused ultrasound over 4 years

Desmoid tumors are a rare form of cancer, which show locally aggressive invasion of surrounding tissues and may occur anywhere in the body. Treatment options comprise conservative watch and wait strategies as tumors may show spontaneous regression as well as surgical resection, radiation therapy, no...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 13; p. 1124244
Main Authors Yeo, Sin Yuin, Bratke, Grischa, Knöll, Peter, Walter, Sebastian Gottfried, Maintz, David, Grüll, Holger
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 09.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Desmoid tumors are a rare form of cancer, which show locally aggressive invasion of surrounding tissues and may occur anywhere in the body. Treatment options comprise conservative watch and wait strategies as tumors may show spontaneous regression as well as surgical resection, radiation therapy, nonsteroidal anti-inflammatory drugs (NSAID), chemotherapy, or local thermoablative approaches for progressive disease. The latter comprises cryotherapy, radiofrequency, microwave ablation, or thermal ablation with high intensity focused ultrasound (HIFU) as the only entirely non-invasive option. This report presents a case where a desmoid tumor at the left dorsal humerus was 2 times surgically resected and, after recurrence, thermally ablated with HIFU under magnetic resonance image-guidance (MR-HIFU). In our report, we analyze tumor volume and/or pain score during standard of care (2 years) and after HIFU treatment over a 4-year follow-up period. Results showed MR-HIFU treatment led to complete tumor remission and pain response.
Bibliography:ORCID: Sin Yuin Yeo, orcid.org/0000-0002-7602-0695; Grischa Bratke, orcid.org/0000-0002-5696-9828; Peter Knöll, orcid.org/0000-0002-2361-9493; Sebastian Gottfried Walter, orcid.org/0000-0002-6203-8616; David Maintz, orcid.org/0000-0002-8942-3776; Holger Grüll, orcid.org/0000-0002-0993-9300
Edited by: Shi Liu, Memorial Sloan Kettering Cancer Center, United States
Reviewed by: Francesco Fiore, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Italy; Lars Lindner, Ludwig Maximilian University of Munich, Germany
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2023.1124244